Richard Pzena's top holdings (May 2026) include Magna International Inc. (MGA), a global automotive supplier specializing in mobility technology, systems, and components.

Richard Pzena is the founder and co-Chief Investment Officer of Pzena Investment Management. The firm focuses on a disciplined, value-oriented investment approach. Their strategy involves in-depth research to identify companies trading below their intrinsic value.

Magna International Inc. (MGA)

Magna International Inc. operates as a global automotive supplier, providing mobility technology, systems, and components to car manufacturers worldwide. Its expansive product range supports everything from vehicle exteriors and seating to powertrains and complete vehicle assembly. The company’s market capitalization stands at $17.55 billion, while the current value of Richard Pzena's holding is $1.61 billion. Analysts have set a price target of $64.0 for Magna, and its discounted cash flow analysis suggests a value of $80.3 per share.
Here's an overview of Richard Pzena's trades in Magna International Inc.:

Humana Inc. (HUM)

Humana Inc. is a health and well-being company primarily focused on government-sponsored healthcare programs, including Medicare and Medicaid. It offers health insurance products and a variety of health care services across the United States. With a market capitalization of $25.84 billion, Richard Pzena's position in Humana is currently valued at $1.29 billion. Its discounted cash flow value is indicated at $339.34, and analysts generally target a price of $220.0 for the stock.
Here's an overview of Richard Pzena's trades in Humana Inc.:

UBS Group AG (UBS)

UBS Group AG is a global financial services firm headquartered in Switzerland, offering comprehensive wealth management, investment banking, asset management, and retail and corporate banking services to a global client base. The company commands a market capitalization of $130.87 billion. The current value of Richard Pzena’s position in UBS is $1.17 billion, with a discounted cash flow analysis suggesting a value of $83.28.
Here's an overview of Richard Pzena's trades in UBS Group AG:

CVS Health Corp (CVS)

CVS Health Corp operates as a diversified health solutions company, encompassing pharmacy benefits management, a large network of retail pharmacies, and health insurance offerings. This holding in Richard Pzena's portfolio is currently worth $1.15 billion, and the company carries a market capitalization of $99.16 billion. The discounted cash flow value for CVS Health is $81.74, while analysts have a consensus price target of $93.25.
Here's an overview of Richard Pzena's trades in CVS Health Corp:

Baxter International Inc. (BAX)

Baxter International Inc. is a global medical technology company offering a diverse portfolio of essential products for hospitals and kidney patients. The firm develops, manufactures, and markets products for acute and chronic medical conditions. Baxter International has a market capitalization of $9.38 billion, and Richard Pzena's position is currently valued at $1.13 billion. Analysts generally set a price target of $21.78 for the company, which also has a discounted cash flow value of $39.16 per share.
Here's an overview of Richard Pzena's trades in Baxter International Inc.: